(Q34732842)

4 August 2017

1 reference

title

Indications and efficacy of the human papillomavirus vaccine (English)

1 reference

4 August 2017

1 reference

Amy A Hakim

1

1 reference

4 August 2017

Paul S Lin

2

1 reference

4 August 2017

Sharon Wilczynski

3

1 reference

4 August 2017

Kimhuynh Nguyen

4

1 reference

4 August 2017

Billie Lynes

5

1 reference

4 August 2017

Mark T Wakabayashi

6

1 reference

4 August 2017

1 December 2007

1 reference

Current Treatment Options in Oncology

4 August 2017

1 reference

4 August 2017

8

1 reference

4 August 2017

6

1 reference

4 August 2017

393-401

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-007-0050-0

4 August 2017

0 references

cites work

The causal relation between human papillomavirus and cervical cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0050-0

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0050-0

Parental response to the introduction of a vaccine against human papilloma virus

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-007-0050-0

General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)

21 January 2018

1 reference

12 December 2020

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

1 reference

12 December 2020

ACOG Committee Opinion #300: Cervical cancer screening in adolescents

1 reference

12 December 2020

Cancer statistics, 2004

1 reference

12 December 2020

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

1 reference

12 December 2020

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

12 December 2020

ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study

1 reference

12 December 2020

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

1 reference

12 December 2020

High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)

1 reference

12 December 2020

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

12 December 2020

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

12 December 2020

Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma

1 reference

12 December 2020

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

12 December 2020

Who should be vaccinated against human papillomavirus?

1 reference

12 December 2020

Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women

1 reference

12 December 2020

Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia.

1 reference

12 December 2020

ACOG Committee Opinion No. 344: Human papillomavirus vaccination

1 reference

12 December 2020

Advances in prevention of cervical cancer and other human papillomavirus-related diseases

1 reference

12 December 2020

Delivering on the promise: HPV vaccines and cervical cancer

1 reference

12 December 2020

Human papillomaviruses in head and neck carcinomas

1 reference

12 December 2020

Efficacy and other milestones for human papillomavirus vaccine introduction

1 reference

12 December 2020

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

12 December 2020

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

10.1007/S11864-007-0050-0

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference